Biopharma Industry is Seeing Merit in Early Preclinical Strategies: The biopharma industry is seeing more merit in strategizing clinical and commercial drug development as early as the preclinical phase.
| Publicado en: | BioPharm International Vol. 34; no. 11; pp. 36 - 38 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Nov2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |